Clinical implications of microRNAs in human glioblastoma
about
Gliomas and the vascular fragility of the blood brain barrierA novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signalingTumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma.The challenges and the promise of molecular targeted therapy in malignant gliomas.Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells.The regulation of cancer cell migration by lung cancer cell-derived exosomes through TGF-β and IL-10miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.Emerging biomarkers in glioblastomaAnti-cancer Therapies in High Grade Gliomas.Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.Extracellular RNA mediates and marks cancer progression.Molecular and genetic pathways in gliomas: the future of personalized therapeutics.MicroRNA as potential biomarkers in Glioblastoma.Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept.A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.An update on the epigenetics of glioblastomas.miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.Insights into molecular therapy of glioma: current challenges and next generation blueprintMetformin treatment reduces temozolomide resistance of glioblastoma cells.Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions.The biological roles and clinical implications of microRNAs in clear cell renal cell carcinoma.A Critical Overview of Targeted Therapies for Glioblastoma
P2860
Q28081953-D785D317-E48F-4F34-B462-2766AB119131Q28537845-7D06D0E7-4983-4619-9763-C3140C92904CQ34221714-64E2B9BB-C871-4F8A-B417-FBA6213428D8Q35214534-F4A7E70C-781A-4FF5-8A92-41DC87E31690Q36503188-A86C1DB1-6056-4617-9980-0EEBAD5F4B73Q36524867-E40DD04F-F213-4487-AE12-9D18E25D121FQ36545707-8F0CA340-486B-41E7-98A3-00544040B572Q37226521-41C497B5-99DE-430A-B0FB-F8AEE38E4427Q37290626-6D6E888E-1568-4862-B8EB-AAC210A3EF8BQ38109551-C93FD4D9-49CE-4D9A-9B56-86BC4E3D6672Q38208372-D17AC83B-5C54-4E96-BC3F-D3B11899E58CQ38233171-2B704CEE-38E6-46C1-83D6-BF9FD713E625Q38590626-4C9E355A-0D75-425E-A557-D564895E0FC0Q38830931-B1E25665-3139-4E0B-9DD6-EE3E8EA834A3Q38935921-987CB03C-7326-4D5D-835D-88D65A36DD74Q38944047-A781CA56-FCEE-4931-BA3F-185062AF2B4DQ39020586-23BDED2F-0435-4634-B380-ADDA6B8DE2A7Q39187306-EBA535C1-52FE-423E-B927-41D3E326DBE7Q39239705-C13993DA-4170-4C9A-A12B-A30F66C51795Q42157978-B6F95742-33BA-45BC-A327-4ECEF6182B4DQ47351319-1B78FEF1-E923-4791-AF40-4DDB0D40821BQ58122179-B97551C5-28BA-47F2-9B48-5CBE1B37365E
P2860
Clinical implications of microRNAs in human glioblastoma
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical implications of microRNAs in human glioblastoma
@en
type
label
Clinical implications of microRNAs in human glioblastoma
@en
prefLabel
Clinical implications of microRNAs in human glioblastoma
@en
P2093
P2860
P356
P1476
Clinical implications of microRNAs in human glioblastoma
@en
P2093
Akira Nakamizo
Koji Yoshimoto
Masahiro Mizoguchi
Tomio Sasaki
Toshiyuki Amano
Yanlei Guan
P2860
P356
10.3389/FONC.2013.00019
P577
2013-02-07T00:00:00Z